Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 1 year ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 7 months ago

Heart Failure

Prevention & Chronic Conditions
HFA 24: The TELESAT Study
Author(s): Nicolas Girerd Added: 1 year ago
HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients… View more

Heart Failure

Digital Health
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis
Author(s): Added: 1 month ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview… View more

Heart Failure
Luke Laffin
Job title: Preventive Cardiologist
Dr Luke Laffin is a physician in the Preventive Cardiology & Rehabilitation Section in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He sees patients at Cleveland Clinic main campus and is the medical director of cardiac rehabilitation. Specialty Interests: Cardiology, preventive cardiology, hypertension (high… View more
HFA 24: Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
Author(s): Michael Kiernan Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure… View more

Heart Failure

Digital Health
Home Sleep Apnoea Testing in Heart Failure
Author(s): Rebecca Steinberg , Andrew R Spector , Todd McVeigh , et al Added: 3 weeks ago

Heart Failure
Philip B Adamson
Job title: Medical Director
Dr Philip Adamson is Medical Director of the Oklahoma Foundation for Cardiovascular Research and founder of the Heart Failure Institute at Oklahoma Heart Hospital. Dr Adamson received his MD & master's of science in cardiovascular physiology and heart failure from the University of Oklahoma Health Sciences Center. He joined the faculty at the University of Oklahoma as a Warren Foundation… View more
Omron logo
Omron Healthcare is a manufacturer of medical equipment for therapy and health monitoring. Our range of products includes blood pressure monitors, portable ECG, augmentation index device, respiratory therapy devices, electronic fever thermometers and body fat monitors among others. Our eco-friendly products are not only known for their high quality and performance standards, but also for their… View more